By Counterforce Health Team in Qalsody (tofersen) —

How to Get Qalsody (Tofersen) Covered by UnitedHealthcare in California: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Qalsody Covered by UnitedHealthcare in California

Qalsody (tofersen) requires prior authorization through UnitedHealthcare's OptumRx with strict documentation requirements. You'll need genetic confirmation of SOD1 mutation, neurologist involvement, baseline ALSFRS-R scores, and evidence of riluzole/edaravone trial or contraindication. Submit via the UnitedHealthcare provider portal with complete clinical documentation. If denied, California's Independent Medical Review (IMR) provides strong external appeal rights. First step: Verify your plan type and gather SOD1 genetic testing results today.

Table of Contents

  1. What This Guide Covers
  2. Before You Start: Verify Your Coverage
  3. Gather Required Documentation
  4. Submit Your Prior Authorization Request
  5. Follow-Up and Tracking
  6. Typical Timelines in California
  7. If You're Asked for More Information
  8. If Your Request is Denied
  9. Renewal and Re-Authorization
  10. Quick Reference Checklist

What This Guide Covers

This guide helps patients with ALS due to SOD1 mutation and their healthcare teams navigate UnitedHealthcare's prior authorization process for Qalsody (tofersen) in California. We'll walk through each step from initial documentation to appeals, including California-specific external review rights.

Who this helps:

  • Patients diagnosed with SOD1-positive ALS
  • Neurologists and clinic staff managing prior authorizations
  • Caregivers advocating for coverage

Expected outcome: With proper documentation, most SOD1-positive ALS cases that meet FDA criteria can achieve approval, though initial denials are common and require persistence.

Before You Start: Verify Your Coverage

Check Your Plan Type

UnitedHealthcare manages different plan types with varying rules:

Plan Type Regulator Appeal Rights Pharmacy Benefit
Commercial HMO/PPO California DMHC Internal + IMR OptumRx
Medicare Advantage CMS + DMHC Internal + External Review OptumRx
Medicaid (Medi-Cal) DHCS + DMHC Internal + IMR OptumRx
Tip: Call the member services number on your insurance card to confirm your plan type and pharmacy benefits manager.

Verify Network Status

Ensure your neurologist is in-network with UnitedHealthcare. Out-of-network providers face additional barriers and may require referrals or exceptions.

Confirm Formulary Placement

Qalsody is typically on UnitedHealthcare's highest specialty tier, requiring prior authorization regardless of plan type. Check your plan's formulary through the UnitedHealthcare member portal or call member services.

Gather Required Documentation

Essential Clinical Documentation

SOD1 Mutation Confirmation:

  • Genetic testing report confirming SOD1 gene mutation
  • Laboratory report must be less than 12 months old
  • Include specific mutation details if available

ALS Diagnosis Documentation:

  • Neurologist consultation notes
  • EMG/nerve conduction studies
  • Clinical assessment confirming ALS diagnosis
  • ICD-10 code: G12.21 (Amyotrophic lateral sclerosis)

Baseline Functional Assessment:

  • ALSFRS-R (ALS Functional Rating Scale-Revised) score
  • Must be completed within 3 months of request
  • Include detailed scoring for all 12 domains
  • ALSFRS-R scoring guidance

Step Therapy Documentation:

  • Trial history with riluzole and edaravone, OR
  • Medical contraindications to these therapies, OR
  • Documentation of intolerance/adverse effects

Prescriber Qualifications:

  • Neurologist attestation or consultation notes
  • Preferably from neuromuscular or ALS specialist
  • Include provider NPI and credentials

Additional Supporting Documentation

Ventilation Status:

  • Confirmation patient is NOT dependent on invasive ventilation
  • Respiratory function tests if available
  • Tracheostomy status documentation

Baseline Biomarkers (if available):

  • Neurofilament light chain (NfL) levels
  • Note: Coverage for NfL testing varies; confirm with UnitedHealthcare

Submit Your Prior Authorization Request

Submission Methods

Primary Method: UnitedHealthcare Provider Portal

  • Log in at UHCProvider.com
  • Navigate to Prior Authorization section
  • Upload all documentation as single comprehensive packet

Alternative: OptumRx Fax

  • Use plan-specific fax number (verify current number through provider portal)
  • Include cover sheet with member ID and drug name
  • Send all documents in single transmission

Clean Request Packet Checklist

✓ Completed prior authorization form ✓ SOD1 genetic testing results ✓ Neurologist consultation notes ✓ ALSFRS-R baseline assessment ✓ Step therapy documentation (riluzole/edaravone) ✓ Ventilation status confirmation ✓ Detailed clinical rationale letter ✓ FDA prescribing information reference

Note: Incomplete requests are the leading cause of delays. Submit all documentation together rather than piecemeal.

Specialty Pharmacy Coordination

UnitedHealthcare typically requires specialty pharmacy dispensing for Qalsody. Coordinate with:

  • OptumRx specialty pharmacy network
  • Your neurologist's preferred specialty pharmacy
  • Hospital or infusion center (for intrathecal administration)

Follow-Up and Tracking

When to Call

  • 48-72 hours after submission: Confirm receipt and completeness
  • Day 10-12: Check processing status
  • Day 25: Escalate if no decision (standard review is 30 days)

What to Ask

Sample script for calling UnitedHealthcare: "I'm calling about prior authorization request [reference number] for Qalsody (tofersen) for member [ID]. Can you confirm the status and let me know if any additional information is needed?"

Document Everything

  • Reference numbers from all calls
  • Names of representatives spoken with
  • Dates and times of interactions
  • Any additional requests for information

Typical Timelines in California

Standard Review Process

Step Timeline California Law
Initial Review 30 calendar days Health & Safety Code §1367.01
Urgent/Expedited 72 hours Required for life-threatening conditions
Additional Information Request 5 business days to respond Clock stops until received

Factors That Speed Decisions

  • Complete documentation submitted upfront
  • Clear clinical rationale
  • Neurologist involvement
  • Urgent medical necessity

Factors That Slow Decisions

  • Missing SOD1 genetic testing
  • Incomplete ALSFRS-R documentation
  • Non-neurologist prescriber
  • Unclear step therapy history

If You're Asked for More Information

Common Requests

Medical Necessity Questions:

  • Provide updated ALSFRS-R scores
  • Include disease progression documentation
  • Reference FDA labeling for SOD1-positive ALS

Step Therapy Clarification:

  • Document specific riluzole/edaravone trials
  • Include dates, doses, and reasons for discontinuation
  • Provide contraindication documentation if applicable

Handling Literature Requests

UnitedHealthcare may request supporting literature. Include:

If Your Request is Denied

Common Denial Reasons and Fixes

Denial Reason How to Fix Documentation Needed
No SOD1 mutation documented Submit genetic testing Laboratory report with SOD1 confirmation
Non-neurologist prescriber Get neurologist consultation Specialist evaluation and recommendation
Missing baseline ALSFRS-R Complete functional assessment ALSFRS-R score within 3 months
Step therapy not met Document prior treatments Riluzole/edaravone trial history or contraindications
Ventilator dependency Clarify ventilation status Respiratory assessment showing non-invasive support only

Internal Appeals Process

First Level Appeal:

  • Submit within 180 days of denial
  • Include all original documentation plus denial response
  • Add any new supporting evidence

Peer-to-Peer Review:

  • Request within 24 hours of denial for urgent cases
  • Neurologist discusses case directly with UnitedHealthcare medical director
  • Often resolves coverage without formal appeal

California External Review (IMR)

If internal appeals fail, California residents have strong external review rights:

Independent Medical Review (IMR):

  • File with California Department of Managed Health Care (DMHC)
  • Free process with binding decisions
  • Standard IMR: 45 days; Expedited: 7 days
  • Call DMHC Help Center: (888) 466-2219
  • Apply online: healthhelp.ca.gov
From our advocates: "We've seen several Qalsody denials overturned through California's IMR process when patients provided comprehensive SOD1 documentation and clear evidence of disease progression. The key is submitting all clinical evidence upfront and clearly demonstrating medical necessity for this specific SOD1-targeted therapy."

California's IMR success rates for specialty drug denials vary, but medical necessity cases have higher reversal rates than experimental therapy denials. For ALS medications with FDA approval, focus on medical necessity rather than experimental therapy arguments.

Renewal and Re-Authorization

When to Start Renewal Process

Begin renewal 45-60 days before current authorization expires to avoid treatment interruption.

Required Renewal Documentation

Updated Clinical Assessment:

  • Current ALSFRS-R scores showing disease progression or stabilization
  • Neurologist notes on treatment response
  • Adverse event monitoring
  • Continued SOD1 mutation documentation

Biomarker Updates (if available):

  • Follow-up neurofilament light chain (NfL) levels
  • Correlation with functional scores
  • Evidence of treatment benefit or slowed progression

Ongoing Medical Necessity:

  • Continued neurologist involvement
  • Updated treatment goals
  • Assessment of alternative therapies

Renewal Timeline

Most initial authorizations are granted for 12 months. Renewal requests follow the same 30-day review timeline unless expedited review is requested due to urgent medical need.

Quick Reference Checklist

Before Submitting

□ Verify UnitedHealthcare plan type and OptumRx coverage □ Confirm neurologist is in-network □ Gather SOD1 genetic testing results □ Complete baseline ALSFRS-R assessment □ Document riluzole/edaravone history □ Confirm non-invasive ventilation status

Submission Packet

□ Prior authorization form (plan-specific) □ SOD1 mutation confirmation □ Neurologist consultation notes □ ALSFRS-R baseline scores □ Step therapy documentation □ Clinical rationale letter □ FDA prescribing information

After Submission

□ Track reference number □ Follow up at 48-72 hours □ Check status weekly □ Respond promptly to information requests □ Prepare appeal documentation if needed

If Denied

□ Request peer-to-peer review (within 24 hours) □ File internal appeal (within 180 days) □ Consider California IMR if internal appeals fail □ Contact DMHC Help Center for assistance

Counterforce Health helps patients, clinicians, and specialty pharmacies turn insurance denials into targeted, evidence-backed appeals. Our platform analyzes denial letters and plan policies to draft point-by-point rebuttals aligned with payer requirements, pulling the right clinical evidence and regulatory citations to support your case.

Frequently Asked Questions

How long does UnitedHealthcare prior authorization take in California? Standard review is 30 calendar days, but urgent cases must be decided within 72 hours. Complete documentation speeds the process.

What if Qalsody is non-formulary on my plan? Even non-formulary drugs can be covered through prior authorization and medical necessity review. Focus on SOD1-specific indication and lack of alternatives.

Can I request an expedited appeal? Yes, if delay could seriously jeopardize your health or ability to regain function. ALS cases typically qualify for expedited review.

Does step therapy apply if I tried riluzole outside California? Yes, document any prior ALS therapy trials regardless of where they occurred. Include dates, doses, and outcomes.

What's the cost of Qalsody with UnitedHealthcare? Costs vary by plan, but specialty tier copays can be substantial. Check manufacturer copay assistance and patient foundation programs.

How do I file a complaint with California regulators? Contact the DMHC Help Center at (888) 466-2219 or file online at healthhelp.ca.gov for HMO plans, or call California Department of Insurance at (800) 927-4357 for other plans.

Sources & Further Reading

Disclaimer: This guide provides general information about insurance coverage processes and should not be considered medical or legal advice. Coverage decisions depend on individual circumstances, plan benefits, and clinical factors. Always consult with your healthcare provider and insurance plan for specific guidance. For assistance with complex cases, consider consulting with organizations like Counterforce Health that specialize in insurance appeals and prior authorization support.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.